Senior Advisors
  • Home
  • FREE Quotes
  • About YOU
    • Turning 65, Ready to enroll?
    • Working Past Age 65?
    • Already on Medicare, Looking to Save Money?
    • Currently on a Retiree Plan?
  • About Us
  • Products
    • Medicare Supplements & Medicare Advantage >
      • Medicare Supplement - Plan F >
        • Plan F (2022)
        • Plan F (2023)
      • Medicare Supplement - Plan G >
        • Plan G (2022)
        • Plan G (2023)
      • Medicare Supplement - Plan N >
        • Plan N (2022)
        • Plan N (2023)
    • Medicare Part D - Prescription
    • Medicare & Dental
    • International Travel
    • Long-Term Care Insurance
    • Cancer and Heart Attack or Stroke Insurance
    • Medigap Plans
  • Workshops
    • Register for Workshop
    • Watch Workshop Now
  • Carrier Partners
  • Medicare Blog
  • Testimonials
  • Contact Us
  • Become an Agent
  • Areas We Serve
    • Basking Ridge, NJ
    • Bridgewater, NJ
    • Livingston NJ
    • Medford, NJ
    • Mountainside, NJ
    • Mount Laurel, NJ
    • Philadelphia, PA
    • Phoenix, AZ
    • Scotch Plains, NJ
    • Scottsdale, AZ
    • Short Hills, NJ
    • Summit, NJ
    • Westfield, NJ
    • Princeton, NJ
    • Washington Township
    • Monroe Township, NJ
    • Berlin, NJ
  • Medicare FAQs
  • Coffee with Justin
  • Medicare Minute

hhs selects first 10 drugs for negotiation

8/29/2023

0 Comments

 
Picture
In August of 2022, the Federal Government passed the Inflation Reduction Act bill which included numerous provisions related to Medicare drug pricing.

One of the provisions in this Bill will allow HHS (Health and Human Services) to negotiate drug pricing for the Medicare program.  The first 10 drugs were just selected for negotiation and they are listed below.  The negotiation will take several years and the new pricing will take effect in 2026.
  • Eliquis
  • Jardiance
  • Xarelto
  • Januvia
  • Farxiga
  • Entresto
  • Enbrel
  • Imbruvica
  • Stelara
  • Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill

These are all high-cost drugs that we see each year during our Part D review and recommendations so we are looking forward to the lower prices going forward.

However, the impact this will have on the Medicare beneficiary will likely be minimal because of the other changes coming to the Medicare Part D program.  Specifically, there will be a cap on Part D out of Pocket expenses of approximately $3,500 in 2024 and $2,000 in 2025.  So, the Medicare Beneficiary who is taking these expensive medications in 2026 will likely reach their Maximum out of Pocket expense (with or without the drug price negotiation).  We shall see how this all pans out over the next few years.
0 Comments

2024 Medicare Part D Changes

7/12/2023

2 Comments

 
Each year, there are changes to the Part D Prescription Drug Coverage of Medicare.  We won't have visibility to the actual Part D Plans until October 1, but there are some structural changes that occur each year with Part D.  Key updates for 2024 are below.
  • Annual Deductible Limit - increase of $40 from $505 in 2023 to $545 in 2024
  • Initial Coverage Level increase of $370 from $4,660 in 2023 to $5,030 in 2024
  • True-out-of-Pocket Limit increase of $600 from $7,400 in 2023 to $8,000 in 2024

Annual Deductible
The government sets a maximum deductible amount for the Part D Plans.  In 2023, the maximum deductible was $505.  In 2024, this is increasing $40 to $545.  On most of the Part D Plans, the deductible only applies to higher tiered drugs (e.g. Tiers 3, 4, 5).  Also, some Part D Plans have a $0 deductible, or other amounts lower than the maximum deductible.  

Initial Coverage Level
The Initial Coverage Level will increase $370 from $4,660 in 2023 to $5,030 in 2024. This amount is based on the Retail Cost of the Medication for the year (Calendar Year).  Most people (about 85%) do not exceed the Initial Coverage Level and thus continue to pay their Copay/Coinsurance amount for the entire year.  However, for the people that have very expensive medications that exceed the Initial Coverage Level, they will reach the Part D Coverage Gap, aka Donut Hole where they have to pay 25% the cost of their medications.  The increase of $370 to the Initial Coverage level will have a minimal impact on Drug Costs in 2024.  Basically, for those 15% of people with expensive medications, there will be a slight delay to reaching the Part D Donut Hole.

True Out of Pocket Limit (Tro-oP)
The True Out of Pocket limit will increase $600 from $7,400 in 2023 to $8,000 in 2024. The Tro-Op is used to determine when someone exits the Part D Coverage Gap, aka Donut Hole, and moves into Catastrophic Coverage. 

Big Change in 2024: In 2023 (and prior years), when you reached Catastrophic Coverage, you would still have to pay 5% the cost of your drugs for the rest of the year.  In 2024, if you reach Catastrophic Coverage, you will have $0 cost sharing for the rest of the year for your medications.



​Click the link to the video for a more detailed explanation of these changes, including a detailed example for someone who reaches the Part D Donut Hole.
2 Comments

2023 Capitol conference - Washington DC

3/23/2023

2 Comments

 
Every year in February or March, we head to Washington D.C. for the annual Capitol Conference for our Association (National Association of Benefits and Insurance Professional, NABIP; formerly National Association of Health Underwriters, NAHU).

The last couple of years were not the same (due to COVID), but it was great to be back in person this year.

There are key issues (or Talking Points) that our group focuses on each year. We schedule meetings with our Congressman/Congresswoman to discuss these key issues and ask for support to improve the healthcare system.

This year, we met with our new Congressman (Tom Kean, Jr) and we focused on the issues mentioned below:
  • NABIP strongly opposes capping or modifying the individual tax exclusion of employment-based coverage – if this exclusion cap were to be implemented, it would eventually end the employer sponsored health insurance marketplace which covers about 180 Million people.
  • NABIP supports site-neutral rules to deter located based gaming of coverage/fees.  e.g. Hospital system acquire doctor’s offices/facilities and then double the costs, because of new “facility fees” even though it is the same facility/service it was prior to the acquisition.
  • Medicare: NABIP Supports COBRA to be treated as creditable coverage.  - We had bills drafted in prior years to fix this issue with bi-partisan support but never got through the process.  Rep Schrader was a key sponsor in prior years.
  • Medicare: NABIP Supports a new Part D open-enrollment period.  Medicare Beneficiaries in Part D Plans should have the flexibility to make a one-time change during Open Enrollment (Jan 1 – Mar 31) just like Medicare Advantage Plans. 
  • Medicare: NABIP supports excluding licensed agents and brokers from burdensome marketing restrictions - Senator Rounds drafted a bill last year to remove independent agents from CMS definition of TPMO.

As a member of the Medicare Advisory Group of NABIP, the Medicare issues are always close to my heart so I took the lead in discussing these items with Congressman Kean.  He seemed supportive and we look forward to continued discussions to continue to improve the healthcare system for Medicare Beneficiaries and all Americans.


CMS COO - Jonathan blum

Picture
Justin Lubenow introducing Jonathan Blum, CMS Principal Deputy Administrator & Chief Operating Officer
Picture
Justin Lubenow introducing Jonathan Blum, CMS Principal Deputy Administrator & Chief Operating Officer
At this year's conference, I also had the honor of introducing one of our key speakers, Jonathan Blum (CMS Principal Deputy Administrator & Chief Operating Officer).

Mr. Blum spoke about some of the changes CMS (Centers for Medicare & Medicaid Services) has been making to reduce Medicare complaints and improve the overall experience.  There were loud cheers in the audience when Mr. Blum mentioned the additional work his team is doing to limit the misleading and confusing TV Commercials related to Medicare Plans.  He also mentioned the results have already started to show with a large reduction in Medicare complaints from 2021 to 2022.

celebritybootblack.com-Dino wright

Picture
If you are ever in Washington D.C. and you need your shoes shined, Dino Wright is the man to see!  Every year, we see Dino at the Hyatt in Capitol Hill and he does an amazing job getting our shoes ready to go.

Dino is also an incredibly nice guy and great conversationalist; always enjoy our chats and hearing the updates regarding his children's achievements!

​https://www.celebritybootblack.com/the-visionary-dino-wright/
​

2 Comments

Team dinner with Chef Brett Smith

1/21/2023

8 Comments

 
At the end of another successful year, we like to do a team dinner with our staff and significant others. In prior year's, we have gone to a nice steakhouse and had a nice meal.

This year, we tried something different and hosted at our house with a Private Chef, Brett Smith.  It was an amazing meal/experience.

I met Brett years ago, training together at a gym. He is a likable, hard-working guy. I began following him on Social Media and watched him start his business in 2021.  The pictures of his meals look absolutely amazing so I had to give it a try this year for our team dinner.

I don't consider myself a 'foodie' or food critic, so I am not going to go in a lot of detail, but the flavors and presentations were just amazing all night.


Brett's assistant, Brandon was also fabulous. He helped prepare the food, serve the food, pour drinks, clean the dishes, and just about anything we needed.  He helped make an unforgettable night.

In our business (like most small businesses), referrals & testimonials are so important.

If you are looking for a unique & amazing dinner experience, I highly recommend Chef Brett Smith.  You can contact Brett directly for more details.
8 Comments

2022 Year in review

1/11/2023

0 Comments

 
2022 was another busy year for Medicare and for Senior Advisors.

Some of the key highlights can be found in the short video above.
  • 14% increase in Part B premiums from 2021 to 2022
  • April 2022 - Social Security offices reopen 
  • April 2022 - HHS Report on Medicare Advantage Denials
  • August 2022 - Inflation Reduction Act Signed which significantly changes Part D Prescription Pricing
  • Sept 2022 - CMS announces Part B premium and deductible reductions for 2023
  • Senior Advisors Part D recommendations had savings of ~$3.6m in 2022 ($10m+ over the last 5 years)

We hope everyone has a fantastic 2023!

0 Comments

almost $10M in Projected Part D Savings

11/10/2022

5 Comments

 
Picture
Every year in Sept/Oct, we send out reminders to our clients to complete their updated Rx form so we can review their Part D Plans for the following year.

Oct 15 to Dec 7 is the one opportunity each year to review and change the Part D Plan for the following year.  This is a very important opportunity because the Part D Plans change every year; so even if your drugs haven't changed, your current Part D Plan may not be the best Part D Plan for the following year.

Since 2018, we have been tracking the Savings Projections for the Part D Recommendations we send our clients each year.  If someone's current Part D Plan is still the most cost-effective Plan for the following year, it is not included in the Savings calculation.  The Savings calculation just includes Savings Projection for Part D Recommendations that save people money versus keeping their current Part D Plan.

We are very excited that we have saved our clients nearly $10M over the last 5-years with our Annual Part D reviews.



5 Comments

2023 NJ PAAD Income levels released

11/8/2022

2 Comments

 
Picture
Last week, the state of NJ released their 2023 income levels for State Prescription Assistance Programs.  These are very helpful programs for individuals that have lower income and expensive medications.

EFFECTIVE JANUARY 1, 2023
 
The PAAD income eligibility limits for calendar year 2023 are:
  • Less than $42,142 FOR A SINGLE PERSON
  • Less than $49,209 FOR A MARRIED COUPLE
 
The SENIOR GOLD income eligibility limits for calendar year 2023 are:
  • Between $42,142 -$52,142 FOR SINGLE PERSONS
  • Between $49,209 -$59,209 FOR MARRIED COUPLES

Application for both programs can be made via the NJ SAVE paper application, or on-line.
- MORE INFO CAN BE FOUND HERE
- APPLY ONLINE HERE 


2 Comments

2023 Medicare Part B Premiums, IRMAAs, and Deductible

9/27/2022

4 Comments

 
CMS just announced the updated Part B premiums for 2023.
  • The standard Part B Premium REDUCED $5.20/month from $170.10/month in 2022 to $164.90/month in 2023.
  • Part B deductible REDUCED $7 from $233 in 2022 to $226 in 2023.

The main reason for the reduction in the Part B Premiums for 2023 was the very large increase in 2022 due to an Alzheimer's medication, which has since reduced in price and coverage with Medicare.

The Income Related Monthly Adjustment Amounts (IRMAAs) were also updated for 2023.  You can find the tables below for individuals with income greater than $97,000 (or joint filers with income greater than $194,000).  This income is based on your MAGI (Modified Adjusted Gross Income) from your 2021 Tax Return.  These IRMAAs only affect about 7% of people with Medicare Part B.
Picture
If you are in one of the higher income brackets for the Part B IRMAAs, there is an additional IRMAA for the Part D Drug Coverage.  The updated table for 2023 can be found below.
Picture
The table below shows the sum of the Part B Premium, Part B IRMAA, and Part D IRMAA for the higher income brackets for 2023.
Picture
The other changes for 2023 that were included in the announcement are below.
​
If you have a Medicare Supplement Plan F, Plan G, or Plan N, the Part A cost-sharing is fully covered by the Supplement so these changes below will not impact you.

Picture
4 Comments

inflation reduction act of 2022?

8/7/2022

32 Comments

 
You may have seen in the news there is new legislation that may be passing soon in Washington DC called "Inflation Reduction Act of 2022".  The House has already passed the bill (when it was called the Build Back Better Act) and it is close to being passed in the Senate.  If it gets passed in the Senate, the President will sign it into law.

You can find the full text of the bill here, and below is a brief summary (link to Source).

The bill would raise revenue from:
- Imposing a 15% corporate minimum tax rate for companies with higher than $1 billion annual revenue – $313 billion
- Prescription drug price reform to lower prices, including Medicare negotiation of drug prices – $288 billion
- Increased tax enforcement – $124 billion
- Imposing a 1% excise tax on stock buybacks - $73 billion

It would spend this revenue on:
- Continuing for three more years the expansion of Affordable Care Act subsidies originally expanded under the American Rescue Plan Act of 2021 – $64 billion
- Addressing domestic energy security and climate change – $369 billion
- Funding for drought relief - $5 billion
- Deficit reduction – $306 billion


Impacts to Medicare Beneficiaries
There are two main impacts to Medicare Beneficiaries in the bill.
  1. Addition of Hearing Coverage and Hearing Aid Coverage  (Updated August 8, 2022-  Unfortunately, this benefit was removed in the final bill.)
  2. Creation of $2,000 Maximum out of Pocket for Part D Drug Costs starting in 2025 - this looks like a positive change for Medicare beneficiaries.  In the current system, there is technically unlimited exposure for Part D Prescription Drug costs, because there is no Maximum out of Pocket limit.  In the proposed bill, there will be a cap of $2,000 (in 2025, then ironically inflation-adjusted periodically) on Part D Prescription Drug Costs.  For those beneficiaries, with very expensive medication, this will bring some relief starting in 2025.  We shall see what the impact will be to the Part D Premium costs based on this change.

My concerns with the Bill are below.
  • The two main projected revenue sources will likely never meet the $600 Billion revenue projected in the bill.  However, the $400 Billion in projected spending will certainly happen which will likely continue to increase inflation, not reduce inflation.  Ironic.
  • Why am I so pessimistic about the $600 Billion in projected tax revenue?
    • $313 Billion projected from 15% minimum corporate tax rate - these large corporations have entire teams of internal and external accountants that find creative solutions (e.g. moving businesses to other countries) to reduce their tax rates.  The idea that $313 Billion in incremental tax revenue is going to be generated from this new rule just seems overzealous.
    • $288 Billion projected from Prescription Drug Price reform and Medicare negotiation of drug prices.  I am actually supportive of fixing Prescription Drug Pricing in this country.  I think drug pricing is out of control and makes no logical sense in a lot of cases (e.g. expensive drugs that treat chronic conditions and have been around for many years.). The largest lobbying group in Washington DC (by far) is the Pharmaceutical industry ($300 Million+ per year) and they seem to continue to find ways to maintain the current system which provides huge profits for Pharmaceutical companies.  

I really hope my pessimism is incorrect.  If the bill does get passed, I hope these changes work and generate the additional $600 Billion in Tax revenue (plus the other $200 Billion projected).  Otherwise, the additional spending in this bill will continue to drive increased Inflation for many years to come.
32 Comments

2023 Medicare Part D Changes

6/20/2022

3 Comments

 
Each year, there are changes to the Part D Prescription Drug Coverage of Medicare.  We won't have visibility to the actual Part D Plans until October 1, but there are some structural changes that occur each year with Part D.  Key updates for 2023 are below.
  • Annual Deductible Limit - increase of $25 from $480 in 2022 to $505 in 2023
  • Initial Coverage Level increase of $230 from $4,430 in 2022 to $4,660 in 2023
  • True-out-of-Pocket Limit increase of $350 from $7,050 in 2022 to $7,400 in 2023

Annual Deductible
The government sets a maximum deductible amount for the Part D Plans.  In 2022, the maximum deductible was $480.  In 2023, this is increasing $25 to $505.  On most of the Part D Plans, the deductible only applies to higher tiered drugs (e.g. Tiers 3, 4, 5).  Also, some Part D Plans have a $0 deductible, or other amounts lower than the maximum deductible.  

Initial Coverage Level
The Initial Coverage Level will increase $230 from $4,430 in 2022 to $4,660 in 2023. This amount is based on the Retail Cost of the Medication for the year (Calendar Year).  Most people (about 85%) do not exceed the Initial Coverage Level and thus continue to pay their Copay/Coinsurance amount for the entire year.  However, for the people that have very expensive medications that exceed the Initial Coverage Level, they will reach the Part D Coverage Gap, aka Donut Hole where they have to pay 25% the cost of their medications.  The increase of $230 to the Initial Coverage level will have a minimal impact on Drug Costs in 2023.  Basically, for those 15% of people with expensive medications, there will be a slight delay to reaching the Part D Donut Hole.

True Out of Pocket Limit (Tro-oP)
The True Out of Pocket limit will increase $350 from $7,050 in 2022 to $7,400 in 2023. The Tro-Op is used to determine when someone exits the Part D Coverage Gap, aka Donut Hole, and moves into Catastrophic Coverage where they only have to pay 5% the cost of their medications.  The increase of $350 in the Tro-oP only effects about 5% of people (those that would reach Catastrophic Coverage), and it creates a slight delay for when they will reach Catastrophic coverage. 

The net impact to these individuals with expensive drugs is likely about $100 cost increase for the year.


​Click the link to the video for a more detailed explanation of these changes, including a detailed example for someone who reaches the Part D Donut Hole.
3 Comments
<<Previous

    Justin Lubenow

    See bio here

    CLICK HERE TO SEND US A TEXT!

    Archives

    August 2023
    July 2023
    March 2023
    January 2023
    November 2022
    September 2022
    August 2022
    June 2022
    April 2022
    March 2022
    January 2022
    November 2021
    September 2021
    July 2021
    April 2021
    March 2021
    February 2021
    January 2021
    November 2020
    October 2020
    September 2020
    August 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    March 2018
    February 2018
    January 2018
    November 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015

    Categories

    All

    RSS Feed

Our Services
Company

Products & Services
Carrier Partners
About
Testimonials
Contact Us
Moorestown Office |  214 W. Main Street, Suite 101, Moorestown, NJ 08057 | Tel:856-866-8900
 Servicing Moorestown, Cherry Hill, Mount Laurel, Haddonfield, Voorhees, Medford, Marlton,  Philadelphia, surrounding towns, and licensed in 30+ other states as well.
 
Cranford Office        |  15 Alden Street, Suite 8, Cranford, NJ 07016                  | Tel: 908-272-1970 
 Servicing Cranford, Westfield, Summit, Scotch Plains, Mountainside, Berkeley Heights, New      Providence, Basking Ridge, surrounding towns, and licensed in 30+ other states as well.
​
Phoenix Office       |  20715 N Pima Rd, Suite 108, Scottsdale, AZ 85255
        | Tel:  602- 996-1549
Servicing Phoenix, Scottsdale, Peoria, Sun City, Sun City West, Paradise Valley, Fountain Hills, Cave Creek, surrounding towns and licensed in 30+ other states as well.

Email:  info@senior-advisors.com                                     (Se Habla Español -Tel: 908.481.5678)   

We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or ‍1-800-MEDICARE to get information on all of your options.  Not connected with or endorsed by the United States government or the federal Medicare program.
​
​
Copyright © 2023 Senior Advisors, LLC       |     Licensing & Legal     |     Privacy Policy

  • Home
  • FREE Quotes
  • About YOU
    • Turning 65, Ready to enroll?
    • Working Past Age 65?
    • Already on Medicare, Looking to Save Money?
    • Currently on a Retiree Plan?
  • About Us
  • Products
    • Medicare Supplements & Medicare Advantage >
      • Medicare Supplement - Plan F >
        • Plan F (2022)
        • Plan F (2023)
      • Medicare Supplement - Plan G >
        • Plan G (2022)
        • Plan G (2023)
      • Medicare Supplement - Plan N >
        • Plan N (2022)
        • Plan N (2023)
    • Medicare Part D - Prescription
    • Medicare & Dental
    • International Travel
    • Long-Term Care Insurance
    • Cancer and Heart Attack or Stroke Insurance
    • Medigap Plans
  • Workshops
    • Register for Workshop
    • Watch Workshop Now
  • Carrier Partners
  • Medicare Blog
  • Testimonials
  • Contact Us
  • Become an Agent
  • Areas We Serve
    • Basking Ridge, NJ
    • Bridgewater, NJ
    • Livingston NJ
    • Medford, NJ
    • Mountainside, NJ
    • Mount Laurel, NJ
    • Philadelphia, PA
    • Phoenix, AZ
    • Scotch Plains, NJ
    • Scottsdale, AZ
    • Short Hills, NJ
    • Summit, NJ
    • Westfield, NJ
    • Princeton, NJ
    • Washington Township
    • Monroe Township, NJ
    • Berlin, NJ
  • Medicare FAQs
  • Coffee with Justin
  • Medicare Minute